Resultats de la cerca - Kurtis D. Davies
- Mostrar 1 - 20 resultats de 24
- Anar a la pàgina següent
-
1
Molecular Pathways: ROS1 Fusion Proteins in Cancer per Kurtis D. Davies, Robert C. Doebele
Publicat 2013Revisão -
2
-
3
-
4
Dual Mechanism of a Natural CaMKII Inhibitor per Rebekah S. Vest, Kurtis D. Davies, Heather O’Leary, J. David Port, K. Ulrich Bayer
Publicat 2007Artigo -
5
-
6
-
7
-
8
Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation per Kurtis D. Davies, P. LouAnn Cable, Jennifer Garrus, Francis X. Sullivan, Ira von Carlowitz, Yvan Le Huérou, Eli Wallace, Richard Woessner, Stefan Gröss
Publicat 2011Artigo -
9
Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples per Kurtis D. Davies, Anh‐Tuan Le, Jamie Sheren, Hala Nijmeh, Katherine Gowan, Kenneth L. Jones, Marileila Varella‐Garcia, Dara L. Aisner, Robert C. Doebele
Publicat 2018Artigo -
10
Small Molecule Inhibition of MERTK Is Efficacious in Non–Small Cell Lung Cancer Models Independent of Driver Oncogene Status per Christopher T. Cummings, Weihe Zhang, Kurtis D. Davies, Gregory D. Kirkpatrick, Dehui� Zhang, Deborah DeRyckere, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Douglas K. Graham
Publicat 2015Artigo -
11
Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers per Marisa R. Moroney, Kurtis D. Davies, Adam C. Wilberger, Jeanelle Sheeder, Miriam D. Post, Amber Berning, Christine M. Fisher, Carolyn Lefkowits, Saketh R. Guntupalli, Kian Behbakht, Bradley R. Corr
Publicat 2019Artigo -
12
Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer per Jill J. Bastman, Hilary S. Serracino, Yuwen Zhu, Michelle R. Koenig, Valerica Mateescu, Sharon B. Sams, Kurtis D. Davies, Christopher D. Raeburn, Robert C. McIntyre, Bryan R. Haugen, Jena D. French
Publicat 2016Artigo -
13
Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer per Kurtis D. Davies, Sakshi Mahale, David P. Astling, Dara L. Aisner, Anh T. Le, Trista K. Hinz, Aria Vaishnavi, Paul A. Bunn, Lynn E. Heasley, Aik Choon Tan, D. Ross Camidge, Marileila Varella‐Garcia, Robert C. Doebele
Publicat 2013Artigo -
14
Identifying and Targeting <i>ROS1</i> Gene Fusions in Non–Small Cell Lung Cancer per Kurtis D. Davies, Anh T. Le, Mariana F. Theodoro, Margaret C. Skokan, Dara L. Aisner, Eamon M. Berge, Luigi Terracciano, Federico Cappuzzo, Matteo Incarbone, Massimo Roncalli, Marco Alloisio, Armando Santoro, D. Ross Camidge, Marileila Varella‐Garcia, Robert C. Doebele
Publicat 2012Artigo -
15
Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors per Jessica Lake, Andrew M. Donson, Eric Prince, Kurtis D. Davies, Anandani Nellan, Adam L. Green, Jean M. Mulcahy Levy, Kathleen Dorris, Rajeev Vibhakar, Todd C. Hankinson, Nicholas K. Foreman, Mark D. Ewalt, Bette K. Kleinschmidt‐DeMasters, Lindsey M. Hoffman, Ahmed Gilani
Publicat 2019Artigo -
16
Resistance Mechanisms to Targeted Therapies in <i>ROS1</i>+ and <i>ALK</i>+ Non–small Cell Lung Cancer per Caroline E. McCoach, Anh T. Le, Katherine Gowan, Kenneth A. Jones, Laura Schubert, Andrea E. Doak, Adriana Estrada‐Bernal, Kurtis D. Davies, Daniel T. Merrick, Paul A. Bunn, W. Tom Purcell, Rafał Dziadziuszko, Marileila Varella‐Garcia, Dara L. Aisner, D. Ross Camidge, Robert C. Doebele
Publicat 2018Artigo -
17
Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer per Sana D. Karam, Krishna Reddy, Patrick J. Blatchford, Tim Waxweiler, Alicia M. DeLouize, Ayman Oweida, Hilary Somerset, Carrie B. Marshall, Christian D. Young, Kurtis D. Davies, Madeleine Kane, Aik Choon Tan, Xiaojing Wang, Antonio Jimeno, Dara L. Aisner, Daniel W. Bowles, David Raben
Publicat 2018Artigo -
18
Clinical Utility of Cell-Free DNA for the Detection of <i>ALK</i> Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non–Small Cell Lung Cancer per Caroline E. McCoach, Collin M. Blakely, Kimberly C. Banks, Benjamin Levy, Ben M. Chue, Victoria M. Raymond, Anh T. Le, Christine E. Lee, Joseph A. Diaz, Saiama N. Waqar, W. Thomas Purcell, Dara L. Aisner, Kurtis D. Davies, Richard B. Lanman, Alice T. Shaw, Robert C. Doebele
Publicat 2018Artigo -
19
EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases per Aria Vaishnavi, Laura Schubert, Uwe Rix, Lindsay A. Marek, Anh T. Le, Stephen B. Keysar, Magdalena J. Glogowska, Matthew A. Smith, Severine Kako, Natália J. Sumi, Kurtis D. Davies, Kathryn E. Ware, Marileila Varella‐Garcia, Eric B. Haura, Antonio Jimeno, Lynn E. Heasley, Dara L. Aisner, Robert C. Doebele
Publicat 2017Artigo -
20
Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors per Julie W. Reeser, Dorrelyn M. Martin, Jharna Miya, Esko A. Kautto, E. Lyon, Eliot Y. Zhu, Michele R. Wing, Amy Smith, Matthew Reeder, Eric Samorodnitsky, Hannah Parks, Karan R. Naik, Joseph M. Gozgit, Nicholas B. Nowacki, Kurtis D. Davies, Marileila Varella‐Garcia, Lianbo Yu, Aharon G. Freud, Joshua F. Coleman, Dara L. Aisner, Sameek Roychowdhury
Publicat 2017Artigo
Eines de cerca:
Matèries relacionades
Cancer research
Medicine
Biology
Cancer
Internal medicine
Oncology
Genetics
Gene
Lung cancer
Kinase
Receptor
Adenocarcinoma
Cell biology
Crizotinib
Malignant pleural effusion
ROS1
Fusion gene
Targeted therapy
Biochemistry
Pathology
Receptor tyrosine kinase
Tyrosine kinase
Cell cycle
Computational biology
DNA
Molecular biology
Apoptosis
Autophosphorylation
Cabozantinib
Cancer cell